Catalyst Pharmaceuticals Inc

NASDAQ:CPRX  
7.33
+0.31 (+4.42%)
Earnings Announcements

Catalyst Pharmaceuticals Reports First Quarter 2022 Results

Published: 05/10/2022 20:23 GMT
Catalyst Pharmaceuticals Inc (CPRX) - Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results and Provides Corporate Update.
Q1 Revenue Rose 42.7 Percent to $43.1 Million.
Reaffirms FY 2022 Total Revenue Guidance of $195 Million to $205 Million.
Qtrly Earnings per Share $0.12.
Q1 Earnings per Share View $0.14 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $49.22 Million
Adjusted EPS is expected to be $0.17

Next Quarter Revenue Guidance is expected to be $53.31 Million
Next Quarter EPS Guidance is expected to be $0.19

More details on our Analysts Page.